← FDA Drug Approvals (Drugs@FDA)

RAZADYNE ER

NDA · New Drug Application · Sponsor: JANSSEN PHARMS · Approved 2005-04-01

Drug application

FDA Application #

NDA021615

Application type

New Drug Application

Brand name

RAZADYNE ER

Generic name

Galantamine Hydrobromide

Active ingredients

GALANTAMINE HYDROBROMIDE

Dosage form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Marketing status

Discontinued

Sponsor

JANSSEN PHARMS

First approval

2005-04-01

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown